跳转至内容
Merck
CN

218861

Sigma-Aldrich

Casein Kinase II Inhibitor III, TBCA

InSolution, ≥90%

别名:

InSolution Casein Kinase II Inhibitor III, TBCA, ( E)-3-(2,3,4,5-Tetrabromophenyl)acrylic acid, (E)-3-(2,3,4,5-Tetrabromophenyl)acrylic acid

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C9H4Br4O2
化学文摘社编号:
分子量:
463.74
MDL编号:
UNSPSC代码:
12352200
NACRES:
NA.54
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

质量水平

方案

≥90% (HPLC)

表单

liquid

制造商/商品名称

Calbiochem®

储存条件

OK to freeze
avoid repeated freeze/thaw cycles
desiccated (hygroscopic)
protect from light

运输

dry ice

储存温度

−70°C

SMILES字符串

OC(/C=C/C1=CC(Br)=C(Br)C(Br)=C1Br)=O

InChI

1S/C9H4Br4O2/c10-5-3-4(1-2-6(14)15)7(11)9(13)8(5)12/h1-3H,(H,14,15)/b2-1+

InChI key

SVJQCVOKYJWUBC-OWOJBTEDSA-N

一般描述

A cell-permeable tetrabrominated cinnamic acid compound that acts as a potent and ATP-competitive inhibitor of Casein Kinase II (IC50 = 110 nM, Ki = 77 nM) with greater selectivity than TBB (Cat. No. 218697 and Cat. No. 218708) and DMAT against a panel of 28 commonly studied kinases. Shown to efficiently induce apoptosis in Jurkat cells (DC50 = 7.7 µM). The solid form of this compound (Cat. No. 218710) is also available.

生化/生理作用

Cell permeable: yes
Primary Target
CKII
Reversible: yes

包装

Packaged under inert gas

外形

A 25 mM (5 mg/431 µL) solution of Casein Kinase II Inhibitor III, TBCA (Cat. No. 218710) in DMSO.

制备说明

Following initial thaw, aliquot and freeze (-20°C). Aliquots are stable for up to 6 months at -20°C.

其他说明

Pagano, M.A., et al. 2006. Chembiochem,8, 129.

法律信息

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

Toxicity: Irritant (B)

储存分类代码

10 - Combustible liquids

WGK

WGK 1

闪点(°F)

188.6 °F - closed cup - (refers to pure substance)

闪点(°C)

87 °C - closed cup - (refers to pure substance)


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Mario A Pagano et al.
Chembiochem : a European journal of chemical biology, 8(1), 129-139 (2006-11-30)
Abnormally high constitutive activity of protein kinase CK2, levels of which are elevated in a variety of tumours, is suspected to underlie its pathogenic potential. The most widely employed CK2 inhibitor is 4,5,6,7-tetrabromobenzotriazole (TBB), which exhibits a comparable efficacy toward

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持